This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37384963
rdf:type
wikibase:Item
schema:description
2016 թվականի մայիսի 10-ին հրատարակված գիտական հոդված articolo scientifico vedecký článok مقالة علمية نشرت في 10 مايو 2016 наукова стаття, опублікована в травні 2016 wetenschappelijk artikel scientific article published on 10 May 2016 bilimsel makale article científic article scientifique artículu científicu espublizáu en 2016 vetenskaplig artikel artigo científico wissenschaftlicher Artikel videnskabelig artikel научни чланак vědecký článek
p:P577
wds:Q37384963-013E1E72-EB16-445C-B878-5D3F05F5E1DB
wdt:P577
2016-05-10T00:00:00Z
p:P2860
wds:Q37384963-FDB31E98-820F-4EE5-89C9-58108C313E90 wds:Q37384963-FEB6652D-347B-407E-B536-3792F725B933 wds:Q37384963-0C711B2F-B89B-43A1-83B7-4A3FF9709695 wds:Q37384963-1D77E865-385B-4478-BBCA-187FCBF8E13E wds:Q37384963-13362A5C-A5A5-4935-BD84-A410CECB3A47 wds:Q37384963-1B2F428E-9B83-4464-9202-199961177AF7 wds:Q37384963-290E40DC-2AD6-467A-B579-D7226956533F wds:Q37384963-2DABCD52-8A43-4C6B-AFC6-48C8288B078C wds:Q37384963-20947512-1061-4D15-B1DE-CF595AF5D5B1 wds:Q37384963-280136FF-E3D1-43D0-AD8B-EB49B7321C20 wds:Q37384963-42005C03-C4A3-4BC4-ABF4-C34C747B245D wds:Q37384963-3061768A-8F52-410D-85A9-970ADCBDFE41 wds:Q37384963-3A9C25E7-C198-41F8-8F0E-0A653126EF22 wds:Q37384963-52713D2A-7693-40B8-9DC7-840514EA9658 wds:Q37384963-4F9CFB10-2EF4-4670-9012-6CA95D90B3DA wds:Q37384963-51543F4B-B98F-4792-8E49-6DD8621F0CE8 wds:Q37384963-5CFF5AFF-7E80-4B79-A6B6-1E65DB86608E wds:Q37384963-59D72166-6FA8-455C-85ED-6DD749CC3978 wds:Q37384963-617CBDBE-DCF9-4464-B688-3A176812F515 wds:Q37384963-6D153E5F-BBA2-424C-B863-62A1C7531562 wds:Q37384963-5F988AFC-E83E-4D05-A893-9FFE94E6E310 wds:Q37384963-602F0DDF-1375-4204-A076-6539CF4E4E07 wds:Q37384963-89280048-D8F0-4901-884D-DBBD41D882B8 wds:Q37384963-8DD43B39-1DCE-4893-8FE1-447A27AAA37C wds:Q37384963-85A29B58-558A-4F96-9FE1-93FD789C7911 wds:Q37384963-96BDB52C-40C1-491A-942C-CEA2889F92E7 wds:Q37384963-957C18AB-8175-4E26-8A0E-14AC14DCBE45 wds:Q37384963-A914C1B3-16E5-49AB-8D8F-3F91BB69A046 wds:Q37384963-A99F9288-4F20-4BFB-A831-970251F06429 wds:Q37384963-A8A47997-08FA-4CFE-8268-B57AD71B3825 wds:Q37384963-D414305F-3E72-4AAC-B6DF-3591600FEAD8 wds:Q37384963-DAD73A9B-979C-404D-99F9-81B50D4DA691 wds:Q37384963-FC5834D2-A290-4EFA-83E1-A368AF4202A1 wds:Q37384963-AF766E6E-733D-4926-BDA7-7824ADA982B4 wds:Q37384963-B320A4AC-A935-4312-B1F9-8AE58B7126A9
wdt:P2860
wd:Q36513894 wd:Q48273566 wd:Q64133434 wd:Q33960291 wd:Q36230163 wd:Q51607251 wd:Q51977974 wd:Q42676896 wd:Q27860575 wd:Q37022597 wd:Q30574095 wd:Q28254549 wd:Q36805122 wd:Q83248884 wd:Q22241288 wd:Q36340526 wd:Q36424233 wd:Q24632533 wd:Q34308751 wd:Q51381372 wd:Q42671884 wd:Q34661985 wd:Q37017362 wd:Q37637818 wd:Q48263525 wd:Q37969988 wd:Q48264152 wd:Q29620534 wd:Q37868561 wd:Q60661362 wd:Q57417686 wd:Q34699234 wd:Q45160147 wd:Q58217177 wd:Q47606031
p:P2093
wds:Q37384963-C5B7CB5C-3FAF-4D54-AB4E-B86590144089 wds:Q37384963-910DDF18-AE06-40EC-949B-FFC96740CCB4 wds:Q37384963-9984CA89-1F4F-46FC-B808-2A2C8F6DF1C6 wds:Q37384963-9CD7BDBD-EE4D-497D-AD23-F7FE4B672B06 wds:Q37384963-AE5F2E70-5F0F-45D7-A11F-A8510BFC91FD wds:Q37384963-71269DE0-214D-4A5A-AAAE-B6A57A31FAE3
wdt:P2093
I Pittman O J Varnado M A Boustani V T Thieu R Juneja M Yu
rdfs:label
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
skos:prefLabel
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
schema:name
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
p:P1476
wds:Q37384963-9C4EDB20-4324-407B-8B0E-380A61AB3D03
wdt:P1476
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
p:P304
wds:Q37384963-59EB923F-EDE9-49F0-8365-9A44CD419F0B
wdt:P304
820-828
p:P31
wds:Q37384963-5F819695-D225-48BD-B8C9-F8F15157A41C
wdt:P31
wd:Q13442814
p:P921
wds:Q37384963-F2E882B5-F5E4-4392-A747-26751A0FCDC9
wdt:P921
wd:Q3025883
p:P698
wds:Q37384963-CC84B874-8755-4BC9-A389-DF1B491C93D7
wdtn:P698
n11:27161178
wdt:P698
27161178
p:P1433
wds:Q37384963-67FAE05C-7F30-47D6-85EB-88E2994EFEB3
wdt:P1433
wd:Q5270109
p:P433
wds:Q37384963-74DEBA12-8CB9-49C5-8897-879C6C306BE2
p:P478
wds:Q37384963-A9A17614-C5D4-442F-BE63-5D4A549E3AF7
wdt:P433
8
wdt:P478
18
p:P356
wds:Q37384963-9DD8ADC9-B475-4E9B-B2DF-4128A4E1D790
wdtn:P356
n12:DOM.12687
wdt:P356
10.1111/DOM.12687
p:P932
wds:Q37384963-4B6EBA84-14EF-4BB2-B32E-CF4C0B7D55CF
wdt:P932
5089646